Corcept Therapeutics (CORT) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $79.85 --0%
Revenue Growth %: +12.1%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +12.1%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $64.8 million versus the consensus estimate of $69.29 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- AmerX Starts Ideal Power (IPWR) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
